top of page
Search

Happy New year - and UPDATED COVID-19 treatment guidelines!

Jan 5, 2021
1 min read

With the New Year, new guidelines! Our COVID-19 therapeutic working group has revised our COVID-19 management guidelines. Of note, empiric antibiotics are strongly DISCOURAGED for mild and moderate disease. Investigational or off-label therapies should NOT be given outside of clinical trials (several ongoing clinical trials at the MUHC); Criteria are proposed for potential identification of hyperimmune response, with recommendations to consult ID for severe cases.



 
 
 

Recent Posts

See All
Updated Pediatric guidelines

We are happy to announce that the ASP MCH team updated the pediatric guidelines for common infection syndrome in children. Everything is available on the pediatric page of the MUHC ASP website : https

 
 
 
MUHC ASP Annual report 2025-2026

We are pleased to release the MUHC annual report for 2025-2026. It is available on the <<Resources>> page of the website. Below is a brief summary highlighting the key points and challenges of 2025-20

 
 
 

Comments


logo2.png

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada

+1 514-934-1934

bottom of page